Trials / Completed
CompletedNCT01105403
Exploratory Study on POL6326 in Stem Cell Mobilization
A Phase IIa, Proof of Concept Study is to Determine the Degree of Mobilisation of CD34+ Cells Following Administration of POL6326 in Patients With Multiple Myeloma
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 21 (actual)
- Sponsor
- Polyphor Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether POL6326 is safe and clinically active to mobilize hematopoietic stem cells followed by transplantation
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | POL6326 | IV infusion of POL6326 followed by apheresis to collect mobilized stem cells from peripheral blood |
Timeline
- Start date
- 2009-04-01
- Primary completion
- 2014-02-01
- Completion
- 2014-04-01
- First posted
- 2010-04-16
- Last updated
- 2014-04-23
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01105403. Inclusion in this directory is not an endorsement.